Outset Medical (OM) Net Cash Flow (QoQ) (2020 - 2026)
Outset Medical (OM) Net Cash Flow (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.21 Bn | 176.92 Bn | 6.27 Bn |
| 2 | Stryker | 128.90 Bn | 126.02 Bn | 3.81 Bn |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.62 Bn | 67.16 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.39 Bn | 43.72 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 28.44 Bn | 26.16 Bn | 1.98 Bn |
| 7 | Dexcom | 28.39 Bn | 27.27 Bn | 750.30 Mn |
| 8 | Smith & Nephew | 27.03 Bn | 26.46 Bn | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.43 Bn | 2.07 Bn |
| 10 | Outset Medical | 78,728.30 | -286.57 Mn | 12.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -377.34% |
| Dec 31, 2025 | 70.18% |
| Sep 30, 2025 | 91.42% |
| Jun 30, 2025 | 24.37% |
| Mar 31, 2025 | -153.00% |
| Dec 31, 2024 | 2,084.41% |
| Sep 30, 2024 | -180.45% |
| Jun 30, 2024 | 115.64% |
| Mar 31, 2024 | -212.79% |
| Dec 31, 2023 | 35,497.80% |
| Sep 30, 2023 | -555.00% |
| Jun 30, 2023 | 100.05% |
| Mar 31, 2023 | -78.34% |
| Dec 31, 2022 | -77.75% |
| Sep 30, 2022 | 70.09% |
| Jun 30, 2022 | 42.87% |
| Mar 31, 2022 | -41.20% |
| Dec 31, 2021 | -10.04% |
| Sep 30, 2021 | -294.46% |
| Jun 30, 2021 | 152.09% |